Home・Lista de Ações・Baxter International Inc

Baxter International Inc

Fechado

SetorSaúde

28.32 0.96

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

27.44

Máximo

28.37

Indicadores-chave
By Trading Economics
Rendimento	1B -15M
Vendas	-273M 2.7B
EPS	0.36
Rendimento de Dividendos	1.61
Margem de lucro	-0.555
Funcionários	37,500
EBITDA	744M 297M

Recomendações
By TipRanks
Recomendações	Neutro
Previsão para 12 meses	-7.86% downside

Dividendos
By Acuity
Rendimento de Dividendos Médio do Setor	1.61% 2.31%
Próximos Ganhos	29 de out. de 2026
Próxima data de dividendos	30 de set. de 2026
Próxima data de ex-dividendo	28 de ago. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	2.5B 12B
Abertura anterior	27.36
Fecho anterior	28.32

Sentimento de Notícias

By Acuity

23%

77%

60 / 340 Ranking em Healthcare

Baxter International Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

3 de ago. de 2026, 23:02 UTC

Baxter International Inc shares are trading lower in after-market hours. Broader market volatility contributed to this decline without any specific company news.

31 de jul. de 2026, 23:46 UTC

Baxter International shares are lower in after-market trading, following a brief session rise. Rising U.S. Treasury yields and crude oil prices heighten inflation concerns.

30 de jul. de 2026, 23:21 UTC

Baxter International Inc shares are lower in after-market trading, reflecting unusual volatility despite strong performance over the past month.

29 de jul. de 2026, 22:02 UTC

Baxter International Inc. shares are lower in after-market trading, mirroring the broader market's decline amid geopolitical tensions and inflation concerns.

28 de jul. de 2026, 22:41 UTC

Baxter International Inc shares rose in after-market trading, continuing a trend of higher daily closes and remaining above the 20-day moving average.

27 de jul. de 2026, 19:21 UTC

News

Baxter International shares are higher as TD Cowen raises the price target to $24.00, reflecting positive sentiment in the Health Care Equipment sector.

24 de jul. de 2026, 19:02 UTC

Baxter International Inc shares are higher, reflecting market response to a decline in crude oil prices that eased inflationary pressures.

22 de jul. de 2026, 19:56 UTC

News

Baxter International faces scrutiny over weak growth and declining earnings, contributing to lower shares amid broader weakness in the Health Care Equipment sector.

21 de jul. de 2026, 23:01 UTC

Baxter International Inc. shares declined in after-hours trading, reflecting a weak performance despite a slight recovery from earlier session lows.

20 de jul. de 2026, 23:02 UTC

Baxter International Inc shares are higher in after-market trading, reaching 1.27% above Monday's close and near the upper end of their one-month range.

Comparação entre Pares

Variação de preço

Baxter International Inc Previsão

Preço-alvo

By TipRanks

-7.86% parte inferior

Previsão para 12 meses

Média 25.89 USD -7.86%

Máximo 29 USD

Mínimo 21 USD

Com base em 10 analistas de Wall Street que oferecem metas de preço de 12 meses para Baxter International Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

10 ratings

Comprar

Manter

Vender

Com base em 10 analistas que deram avaliações de ações para Baxter International Inc - Dist nos últimos 3 meses.

Sentimento

By Acuity

60 / 340 Ranking em Saúde

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Baxter International Inc

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.